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Background: Surgical-site infection is the most frequent health care-associated infection in the developing world,
with a strikingly higher prevalence than in developed countries We studied the prevalence of resistance to antibiotics
in Enterobacteriaceae isolates from surgical-site infections collected in three major tertiary care centres in Bangui,
Central African Republic. We also studied the genetic basis for antibiotic resistance and the genetic background of
third-generation cephalosporin-resistant (3GC-R) Enterobacteriaceae.
Results: Between April 2011 and April 2012, 195 patients with nosocomial surgical-site infections were consecutively
recruited into the study at five surgical departments in three major tertiary care centres. Of the 165 bacterial isolates
collected, most were Enterobacteriaceae (102/165, 61.8%). Of these, 65/102 (63.7%) were 3GC-R, which were
characterized for resistance gene determinants and genetic background. The blaCTX-M-15 and aac(6′)-Ib-cr genes
were detected in all strains, usually associated with qnr genes (98.5%). Escherichia coli, the most commonly recovered
species (33/65, 50.8%), occurred in six different sequence types, including the pandemic B2-O25b-ST131 group
(12/33, 36.4%). Resistance transfer was studied in one representative strain of the resistance gene content in each
repetitive extragenic palindromic and enterobacterial repetitive intergenic consensus sequence-PCR banding pattern.
Plasmids were characterized by PCR-based replicon typing and sub-typing schemes. In most isolates (18/27, 66.7%),
blaCTX-M-15 genes were found in incompatibility groups F/F31:A4:B1 and F/F36:A4:B1 conjugative plasmids. Horizontal
transfer of both plasmids is probably an important mechanism for the spread of blaCTX-M-15 among Enterobacteriaceae
species and hospitals. The presence of sets of antibiotic resistance genes in these two plasmids indicates their capacity
for gene rearrangement and their evolution into new variants.
Conclusions: Diverse modes are involved in transmission of resistance, plasmid dissemination probably playing a
major role.
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Third-generation cephalosporin-resistant (3GC-R) En-
terobacteriaceae represent a major threat in both hospital
and community settings worldwide [1]. The resistance
is mediated mainly by acquired extended-spectrum
beta-lactamase (ESBL) genes carried by mobile genetic
elements such as plasmids and transposons. This situ-
ation is of great concern, as ESBL enzymes can hydro-
lyse almost all beta-lactams (except carbapenems and
cephamycins) and are frequently associated with genes
that confer resistance to several other classes of anti-
biotic. During the past decade, CTX-M enzymes have
gradually replaced the classical TEM and SHV-type
ESBLs in many countries [1]. Rapid international spread
of CTX-M-15 has been associated with global dissemin-
ation of Escherichia coli clones, such as sequence type
131 (ST131) harbouring blaCTX-M-15 on incompatibility
group (Inc) FII conjugative plasmids [2].
Plasmid-mediated quinolone resistance has emerged in
Enterobacteriaceae, with three mechanisms described:
Qnr, which mediates target protection; AAC(6′)-Ib-cr,
which mediates drug modification; and OqxAB and
QepA, which mediate drug efflux [3]. These mechanisms
increase the minimum inhibitory concentration (MIC)
of fluoroquinolones, thereby facilitating the selection of
mutants with greater resistance in the presence of quin-
olones through sequential chromosomal mutations in
genes coding for the target enzymes, DNA gyrase and
DNA topoisomerase IV [3].
Surgical-site infection is the most frequent health
care-associated infection in the developing world, with a
strikingly higher prevalence than in developed countries
[4]. The alarming global burden of avoidable complica-
tions resulting from unsafe surgery has been highlighted
by the World Health Organization [5]. Few good-quality
data are, however, available in Africa on the phenotypic
antimicrobial resistance of strains associated with surgical-
site infections, and the mechanisms underlying antimicro-
bial resistance are unknown. We studied the prevalence of
resistance to antibiotics in Enterobacteriaceae isolates
from surgical-site infections collected in three major ter-
tiary care centres in Bangui, Central African Republic; we
also studied the genetic basis for antibiotic resistance and
the genetic background of 3GC-R Enterobacteriaceae.
Results
Patients, antibiotic prophylaxis, bacterial strains and
antibiotic susceptibility
A total of 195 patients (97 males, 98 females; mean age,
30.9 years; median age, 29.0 years; interval, 1.0–85.0 years)
with surgical-site infections were included during the
study period in the general surgical departments of the
Complexe Pédiatrique (n = 33), the orthopaedics depart-
ment of the Community Hospital (n = 64), and the generalsurgery (n = 41), gynaecology (n = 46) and urology (n = 11)
departments of the Amitié Hospital. Most of the opera-
tions were class I (110/195, 56.4%) in the Altemeier classi-
fication, mainly with a pre-operative physical status score
of I (115/195, 59.0%). The duration of most operations did
not exceed 2 h (98.0%). Antibiotic prophylaxis was admin-
istered to 193 patients (99.0%), most frequently consisting
of beta-lactams (92.3%), mainly ceftriaxon (93/193, 48.2%),
penicillin G (n = 68, 35.2%) and ampicillin (n = 43, 22.3%).
Of the 195 non-duplicate biological samples taken, 151
were culture positive (77.4%). As 14 cultured specimens
had mixed growth, a total of 165 bacterial isolates were
collected. The bacteria isolated were E. coli (n = 47),
Staphylococcus aureus (n = 44), Enterobacter cloacae (n =
18), Acinetobacter baumanii (n = 11), Klebsiella pneumo-
niae (n = 19), Pseudomonas aeruginosa (n = 8), Proteus
mirabilis (n = 8), Morganella morganii (n = 3), Salmonella
spp. (n = 2), Enterobacter aerogenes (n = 2), Enterobacter
amnigenus (n = 1), Enterobacter sakazakii (n = 1) and
K. oxytoca (n = 1).
Neither P. aeruginosa nor A. baumanii was resistant
to imipenem, whereas 9% (4/44) of S. aureus isolates
were methicillin-resistant, and 63.7% (65/102) of Entero-
bacteriaceae (33 E. coli, 16 Enterobacter cloacae, 10
K. pneumoniae, 2 Proteus mirabilis, 1M. morganii, 1
Enterobacter amnigenus, 1 Enterobacter sakazakii and 1
K. oxytoca) were resistant to 3GC-R antibiotics. C3G-R
Enterobacteriaceae strains were resistant to all the
beta-lactams tested, except for cefoxitin (24.6% resist-
ance, only Enterobacter cloacae strains), and all were
susceptible to ertapenem (MIC, < 0.008–0.25 mg/L). In
addition, they were characterized by high rates of resist-
ance to netilmicin (n = 49, 75.4%), kanamycin (n = 54,
83.3%), gentamicin (n = 61, 93.9%), tetracycline (n = 60,
92.4%), ciprofloxacin (n = 55, 84.8%) and cotrimoxazole
(n = 62, 95.5%), and a high rate of susceptibility to ami-
kacin (n = 64, 98.5%). The double-disc synergy test was
positive for all strains. Older patients were more suscep-
tible to C3G-R Enterobacteriaceae infection than youn-
ger ones (p = 0.04) (Table 1).
Antibiotic resistance determinants and replicons in C3G-R
Enterobacteriaceae strains
The blaCTX-M-15 and aac(6′)-Ib-cr genes were detected
in all strains. Of the 64 (98.5%) qnr-positive strains, 62
were qnrB, 56 were qnrS and none were qnrA, with 55
strains each harbouring 2 qnr genes.
REP-PCR, ERIC-PCR and multilocus sequence typing of
C3G-R Enterobacteriaceae
REP- and ERIC-PCR analysis showed 15 patterns for E.
coli strains, 6 for Enterobacter cloacae, 5 for K. pneumo-
niae and 2 for P. mirabilis. Three clones were found in
at least two surgical departments in the same hospital
Table 1 Risk factors for infection with Enterobacteriaceae










CI 34.6–42.7 28.9–34.5 1.03 0.04
Gender, %
Female 45.9 54.1 0.79 0.48
Preoperative antibiotic prophylaxisa, %
Yes 46.3 53.7 1.27 0.48
Postoperative antibiotic prophylaxisb, %
Yes 43.6 56.4 1.27 0.48
Surgery in past 12 months, %
Yes 45.0 55.0 1.14 0.69
Hospitalization in past 12 months, %
Yes 35.3 64.71 0.69 0.49
Altemeier wound class, %
1 42.7 57.3 0.93
2 44.4 55.6
3–4 42.8 57.2
American society of anesthesiologists physical status score, %
1 42.6 57.4 0.45
2 37.0 62.0
3 66.7 33.3
Length of operation, %
<30min 39.0 60.0 0.25
30 min–1 h 41.3 58.7
1–2 h 46.5 53.5
>2 h 75.0 25.0
Type of surgery, %
Urology 50.0 50.0 0.31
Orthopaedics 51.8 48.2
General surgery 34.6 65.4
Gynaecology 40.0 60.0
Delay between surgery and surgical-site infection (days), %
<15 43.8 56.2 0.83
≥15 43.0 57.0
OR, odds ratio.
aAntibiotics administered ≤ 60 min before the start of surgery.
bAntibiotics administered immediately after surgery.
Rafaï et al. BMC Microbiology  (2015) 15:15 Page 3 of 10and six clones in at least two different tertiary care cen-
tres: two Enterobacter cloacae clones, three K. pneumo-
niae clones and three E. coli clones (Tables 2 and 3).
Six multilocus STs were found in the 33 E. coli
isolates: ST131 (six clones, n = 12), ST10 (four clones,
n = 12), ST405 (two clones, n = 2), ST156 (one clone,n = 5), ST354 (one clone, n = 1) and ST146 (one clone,
n = 1) (Table 2). All the ST131 isolates corresponded to
the multi-resistant pandemic E. coli B2-O25b-ST131
group.
Resistance transfer determination of C3G-R strains
Resistance transfer assays were performed on one strain
randomly selected for each REP- and ERIC-PCR pattern.
Transfer of ESBL by conjugation with E. coli J53-2 was
successful for 22 (64.7%) of the 34 ESBL clones, which
consisted of 17 E. coli isolates, 4 Enterobacter cloacae
and 1 Enterobacter amnigenus. ESBL transfer by plasmid
DNA electroporation into E. coli DH10B was successful
for 5 (41.7%) of the 12 remaining isolates: 2 K. pneumo-
niae isolates, 2 P. mirabilis and 1 Enterobacter cloacae.
The presence of blaCTX-M-15 and aac(6′)-Ib-cr was
confirmed by PCR in the 27 transconjugants and trans-
formants (Table 4). The plasmid harbouring the
blaCTX-M-15 gene was systematically associated with
aac(6′)-Ib-cr, in contrast to qnr genes, as no qnrS and
45.8% (11/24) of qnrB genes were co-transferred with
blaCTX-M-15. Additional resistance genes (to amino-
glycoside, chloramphenicol, nalidixic acid, tetracycline,
sulfamide and trimethoprim-sulfamethoxazole) were
probably transferred, as shown by antimicrobial sus-
ceptibility testing (Table 4).
Genetic support of resistance determinants
PCR-based replicon typing in the 27 transconjugants
and transformants demonstrated the presence of plas-
mids of the incompatibility groups IncF (n = 24, 88.9%)
and IncHI2 (one Enterobacter cloacae) (Table 4). The
plasmid in two P. mirabilis isolates could not be typed.
In the incompatibility group IncF, identical replicon ST
were found in most isolates: F31:A4:B1 (n = 14, 51.9%;
11 E. coli, 2 Enterobacter cloacae and 1 Enterobacter
amnigenus) and F36:A4:B1 (n = 4, 14.8%; 3 E. coli and 1
Enterobacter cloacae). These two conjugative plasmids
were found in strains collected from different hospitals.
The other combinations were F1:A1:B1 (one E. coli), F1:
A1:B20 (one E. coli), Fnew:A-:B20 (one E. coli and one
Enterobacter cloacae) and K4:-:B- (two K. pneumoniae)
(Table 4).
Discussion
Enterobacteriaceae strains were the microorganisms
most frequently associated with surgical-site infections,
of which 65 (63.2%) were 3GC-R, as described previ-
ously in Africa [6]. Cross-transmission probably plays a
major role, as suggested by the fact that patients in dif-
ferent surgery departments and different hospitals
shared clonally related strains. This was the case not
only for K. pneumoniae and Enterobacter cloacae strains,
which are well known to be highly diffusible in hospital
Table 2 Molecular characteristics of third-generation cephalosporin-resistant Escherichia coli associated with surgical
site infection




ESBL type (n) PMQR determinantsa (n)
10 (12) A (8) A/GS (6), A/G (1), A/U (1) CTX-M15 (8) QnrB (8), QnrS (4), AAC(6′)-1b-cr (8)
B (2) A/GS (1), C/O (1) CTX-M15 (2) QnrB (2), QnrS (2), AAC(6′)-1b-cr (2)
C (1) CP/GS (1) CTX-M15 (1) QnrS (1), AAC(6′)-1b-cr (1)
D (1) C/O (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
146 (1) E (1) A/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
131 (12) F (1) A/GS (1) CTX-M15 (1) QnrB (1), AAC(6′)-1b-cr (1)
G (3) A/GS (3) CTX-M15 (3) QnrB (3), QnrS (3), AAC(6′)-1b-cr (3)
H (1) C/O (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
I (1) A/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
J (5) C/O (3), A/GS (1), CP/GS (1) CTX-M15 (5) QnrB (4), QnrS (4), AAC(6′)-1b-cr (5)
K (1) A/U (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
156 (5) L (5) CP/GS (3), C/0 (2) CTX-M15 (5) QnrB (5), QnrS (5), AAC(6′)-1b-cr (5)
354 (1) M (1) CP/GS (1) CTX-M15 (1) QnrS (1), AAC(6′)-1b-cr (1)
405 (2) N (1) CP/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
O (1) A/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1b-cr (1)
A/GS, Amitié Hospital/general surgery; A/G, Amitié Hospital/gynaecology; A/U, Amitié Hospital/urology; C/O, Community Hospital/orthopaedics; CP/GS, Complexe
Pédiatrique/general surgery; ESBL, extended-spectrum beta-lactamase; PMQR, plasmid-mediated quinolone resistance.
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for E. coli, in contrast to the situation in developed
countries [8]. Further investigations are needed to iden-
tify the mechanisms of transmission.
E. coli was the most frequent species among C3G-R
Enterobacteriaceae. The 33 isolates belonged to six STs, of
which three corresponded to at least two REP- and ERIC-
PCR patterns, namely ST131, ST405 and ST10. The pan-
demic E. coli B2-O25b-ST131 group has contributed
extensively to global dissemination of CTX-M-15 [2,9], as
has ST405, with the dispersal of both CTX-M-15 and
CTX-M-9 group enzymes [10]. In addition, ST10, which is
typical in the human gut but is also responsible for intes-
tinal and extra-intestinal infections, was recently associ-
ated with dissemination of CTX-M-1, CTX-M-2 and
CTX-M-9 groups [10]. These data, combined with those
from Nigeria, South Africa and Tunisia [11-13], show that
dissemination of pandemic E. coli multi-drug resistant STs
also occurs in African hospitals. The reasons for the wide
dissemination and expansion of these clones are unknown
but may include increased transmissibility, greater ability
to colonize and/or persist in the intestinal tract, enhanced
virulence and more extensive antimicrobial resistance than
other E. coli [14]. The three minor STs have been de-
scribed sporadically in humans and animals, associated
with various CTX-M groups [15,16]: ST146 in Germany,
ST156 in France, Great Britain and Portugal, and ST354
in Italy, Portugal and Spain. Five of the isolates found in
two hospitals in this study were assigned to the ST156
genetic background, indicating its ability to spread.Plasmid typing showed that horizontal gene transfer
by IncF plasmid exchange was probably also involved in
the dissemination of blaCTX-M-15. The ESBL blaCTX-M-15
gene was carried in all strains on plasmids of IncF
incompatibility groups, except in one Enterobacter
cloacae. IncF plasmids were the most prevalent in E. coli
and K. pneumoniae carrying ESBL genes and also genes
that confer resistance to tetracyclines, aminoglycosides
and fluoroquinolones. These plasmids can be consid-
ered pandemic, as they have been detected in different
countries and in bacteria of different origins and
sources. The occurrence of these plasmid types appears
to be closely linked to positive selection exerted by anti-
biotic use, incrementing their prevalence over that in
bacterial populations that are not preselected for anti-
microbial resistance. Their occurrence is also linked to
virulence factors that contribute to the fitness of their
bacterial host [17,18]. In the majority of isolates, includ-
ing the three major E. coli STs, blaCTX-M-15 genes were
found within IncF conjugative plasmids, with identical
replicon ST formulae (F31:A4:B1 and F36:A4:B1), two
plasmids reported to be abundant in humans [19]. The
F31 and F36 alleles differ by only a single point muta-
tion. This, in the context of the diversity of the REP-
and ERIC-PCR patterns of the isolates and their pres-
ence in different species and in different hospitals,
suggests that horizontal transfer of plasmids is probably
an important mechanism of blaCTX-M-15 spread, as
described previously [20]. The dissemination of plas-
mids was probably preceded by the centre-to-centre
Table 3 Molecular characteristics of 32 third-generation cephalosporin-resistant non-Escherichia coli Enterobacteriaceae
associated with surgical-site infections




ESBLtype (n) PMQR determinants (n)a
Enterobacter cloacae (16) A (1) A/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
B (10) A/G (5), A/GS (3), CP/GS (1), C/O (1) CTX-M15 (10) QnrB (10), QnrS (10), AAC(6′)-1bcr (10)
C (1) A/G (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
D (1) A/G (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
E (2) C/O (1), A/G (1) CTX-M15 (2) QnrB (2), QnrS (2), AAC(6′)-1bcr (2)
F (1) C/O (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
Klebsiella pneumonia (10) A (3) A/G (1), A/U (1), C/O (1) CTX-M15 (3) QnrB (3), AAC(6′)-1bcr (3)
B (3) C/O (3) CTX-M15 (3) QnrB, (3) QnrS (3), AAC(6′)-1bcr (3)
C (2) CP/GS (1), C/O (1) CTX-M15 (2) QnrB (2), QnrS (2), AAC(6′)-1bcr (2)
D (1) A/G (1) CTX-M15 (1) QnrS (1), AAC(6′)-1bcr (1)
E (1) A/G (1) CTX-M15 (1) QnrB (1), AAC(6′)-1bcr (1)
Proteus mirabilis (2) A (1) A/GS (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
B (1) C/O (1) CTX-M15 (1) QnrS (1), AAC(6′)-1bcr (1)
Enterobacter amnigenus (1) A (1) A/G (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
Enterobacter sakazakii (1) A (1) C/O (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
Klebsiella oxytoca (1) A (1) A/G (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
Morganella morganii (1) A (1) C/O (1) CTX-M15 (1) QnrB (1), QnrS (1), AAC(6′)-1bcr (1)
A/GS, Amitié Hospital/general surgery; A/G, Amitié Hospital/gynaecology; A/U, Amitié Hospital/urology; C/O, Community Hospital/orthopaedics; CP/GS, Complexe
Pédiatrique/general surgery; ESBL, extended-spectrum beta-lactamase; PMQR, plasmid-mediated quinolone resistance.
aQepA was not found in any isolates.
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indicated by the identification by REP- and ERIC-PCR
of closely related K. pneumoniae, E. coli and Enterobac-
ter cloacae isolates in at least two different hospitals.
Various sets of antibiotic resistance genes within F31:
A4:B1 and F36:A4:B1 plasmids indicate their capacity
for gene rearrangement and their evolution into new
variants. ESBL blaCTX-M-15 and aac(6′)-Ib-cr genes
were inconsistently associated with qnrB on these plas-
mids and also with other resistance genes, as shown by
antimicrobial susceptibility testing of transconjugants.
This suggests the presence of a multidrug resistance
region, as described for IncFII plasmids pEK499 and
pEK516 isolated in the United Kingdom from the E.
coli ST131 group and for the pC15-1a plasmid dissemi-
nated in E. coli STs in Canada [20]. Further mapping of
this region is needed. Frequent association of blaCTX-
M-15, qnrB and aac(6′)-Ib-cr genes has been described
in K. pneumoniae isolates in North, West, Central and
East Africa, consistent with the hypothesis that these
resistance-determinant genes are carried together on
the same plasmid [21]. Such accumulation of resist-
ance gene determinants on the same plasmid and their
dissemination is a matter of concern, especially in
countries with inadequate health care systems, becauseof the shortage of effective antibiotics and the conse-
quences with respect to mortality, length of hospital stay
and hospital costs. In addition, uncontrolled use of anti-
microbial agents through self-medication, inappropriate
antibiotic prescription and the substandard quality of
some drugs favour the spread of antimicrobial resistance
in these countries. The emergence of carbapenem resist-
ance, which has been described in Africa [22] but was not
found in our study, could be a serious challenge for infec-
tion control and antibiotic therapy in the future, as carba-
penems are often the most effective antibiotics against
3GC-R Enterobacteriaceae.Conclusions
This study is of particular importance because of the
difficulty of carrying out such studies in hospitals in
countries with inadequate health care systems. Our data
suggest that diverse modes of transmission of resistance
are involved, probably with a major role of plasmid dis-
semination. All necessary measures should be taken in
African hospitals to prevent nosocomial infections and
the selection of resistant bacteria, with efficient noso-
comial infection surveillance programmes. Standard hy-
giene and especially adherence to hand hygiene policies
Table 4 Resistance genes transferred to transconjugants and electroporants and their replicon type














Escherichia coli 10 A A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 QnrB, AAC(6′)-1b-cr GEN, TOB, NAL
E. coli 10 A A/U QnrB, AAC(6′)-1b-cr IncF F31:A4:B1 QnrB, AAC(6′)-1b-cr GEN, TOB, NAL
E. coli 10 B C/O QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
TET, SUL, SXT
E. coli 10 C P/GS QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr GEN, TOB, CHL, TET
E. coli 10 D C/O QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
TET, SUL, SXT
E. coli 146 E A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F36:A4:B1 AAC(6′)-1b-cr GEN, TOB, CHL, TET
E. coli 131 F A/GS QnrB, AAC(6′)-1b-cr IncF F31:A4:B1 QnrB, AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
NAL, TET, SUL, SXT
E. coli 131 G A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 QnrB, AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
NAL, TET, SUL, SXT
E. coli 131 H A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr GEN, TOB, STR, TET,
SUL, SXT
E. coli 131 I A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F1:A1:B20 AAC(6′)-1b-cr GEN, TOB, CHL, TET, SXT
E. coli 131 J A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F36:A4:B1 AAC(6′)-1b-cr KAN, GEN, TOB, NET,
STR, CHL, TET, SUL, SXT
E. coli 131 J C/O AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr KAN, GEN, TOB, NET,
STR, CHL, TET, SUL, SXT
E. coli 131 K A/U QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 QnrB, AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
NAL, TET, SUL, SXT
E. coli 156 L CP/GS QnrB, QnrS, AAC(6′)-1b-cr IncF Fnew:A-:B20 AAC(6′)-1b-cr KAN, GEN, TOB,SUL,
SXT
E. coli 354 M CP/GS QnrS, AAC(6′)-1b-cr IncF F1:A1:B1 AAC(6′)-1b-cr KAN, GEN, TOB, NET,
STR, TET, SUL, SXT
E. coli 405 N CP/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F31:A4:B1 AAC(6′)-1b-cr GEN, TOB, CHL, TET
E. coli 405 O A/GS QnrB, QnrS, AAC(6′)-1b-cr IncF F36:A4:B1 QnrB, AAC(6′)-1b-cr KAN, GEN, TOB, CHL,
NAL, TET, SUL, SXT
Enterobacter cloacae d A A/GS QnrB, QnrS, AAC(6′)-1bcr IncHI2 Not tested QnrB, AAC(6′)-1bcr KAN, STR, NAL, TET,
SUL, SXT
Enterobacter cloacae d B CP/GS QnrB, QnrS, AAC(6′)-1bcr IncF Fnew:A-:B20 AAC(6′)-1bcr KAN, TOB, STR, TET,
SUL, SXT
Enterobacter cloacae d C A/G QnrB, QnrS, AAC(6′)-1bcr IncF F31:A4:B1 AAC(6′)-1bcr GEN, TOB, STR, CHL,
TET, SUL, SXT











Table 4 Resistance genes transferred to transconjugants and electroporants and their replicon type (Continued)
GEN, TOB, STR, CHL,
NAL, TET, SUL, SXT
Enterobacter cloacae d E C/O QnrB, QnrS, AAC(6′)-1bcr TFe
Enterobacter cloacae d F C/O QnrB, QnrS, AAC(6′)-1bcr IncF F36:A4:B1 QnrB, AAC(6′)-1bcr GEN, TOB, STR, CHL,
NAL, TET, SUL, SXT
Klebsiella pneumoniae d A A/U QnrB, AAC(6′)-1bcr TF
K. pneumoniae d B C/O QnrB, AAC(6′)-1bcr IncF K4:- :B- QnrB, AAC(6′)-1bcr GEN, TOB, STR,
NAL, TET, SUL, SXT
K. pneumoniae d C CP/GS QnrB, QnrS, AAC(6′)-1bcr IncF K4:- :B- QnrB, AAC(6′)-1bcr GEN, TOB, STR,
NAL, TET, SUL, SXT
K. pneumoniae d D A/G QnrS, AAC(6′)-1bcr TF
K. pneumoniae d E A/G QnrB, AAC(6′)-1bcr TF
Proteus mirabilis d A A/GS QnrB, QnrS, AAC(6′)-1bcr NTf
P. mirabilis d B C/O QnrS, AAC(6′)-1bcr NT
Enterobacter
amnigenus
d A A/G QnrB, QnrS, AAC(6′)-1bcr IncF F31:A4:B1 AAC(6′)-1bcr GEN, TOB, TET
Enterobacter sakazakii d A C/O QnrB, QnrS, AAC(6′)-1bcr TF
K. oxytoca d A A/G QnrB, QnrS, AAC(6′)-1bcr TF
Morganella morganii d A C/O QnrS, AAC(6′)-1bcr TF
TF, transfer to the E. coli recipient failed; NT, the plasmid could not be typed; ST, sequence type; PMQR, plasmid-mediated quinolone resistance, A/U, Amitié Hospital/urology; C/O, Community Hospital/orthopaedics;
CP/GS, Complexe Pédiatrique/general surgery; A/GS, Amitié Hospital/general surgery; A/G, Amitié Hospital/gynaecology; KAN, kanamycin; GEN, gentamicin; TOB, tobramycin; NET, netilmicin; SRT, streptomycin; CHL,
chloramphenicol; NA, nalidixic acid; TET, tetracycline; SUL, sulfamide; SXT, co-trimoxazole.
aResistance transfer experiments were carried out on one randomly selected strain representative from all resistance gene content within each Rep- and ERIC-PCR banding pattern.
bQepA were not found in any of the isolates.
cblaCTX-M-15 was found in all transconjugants and transformants.
dnot tested.
eTF indicates that the transfer in the E. coli recipient failed.















The study protocols were approved by the National Eth-
ics Committee of Central African Republic. Written in-
formed consent to participate in the study was obtained
from all patients.
Patients
Patients with a surgical-site infection were recruited
consecutively into the study between April 2011 and
April 2012 in five surgical departments in three major
tertiary care centres in Bangui: the Complexe Pédiatri-
que, the Amitié Hospital and the Community Hospital.
A surgical-site infection was defined as an infection that
occurred at or near a surgical incision within 30 days of
the procedure or within 1 year if an implant was left
in place [23]. Patients who underwent surgery were
followed daily until discharge and surveillance was
extended to 30 days post-operation, at a scheduled visit
to the surgeon. The number of patients who did not
return to the hospital and were lost to follow-up is
unknown. A specific, standardized medical question-
naire was completed to collect demographic data, med-
ical history over the previous 12 months, preoperative
and postoperative antibiotic prophylaxis or treatment,
type of surgery, Altemeier wound class, the American
Society of Anesthesiologists’ physical status score,
length of operation and delay between surgery and
surgical-site infection (Table 1).
Microbiological analysis, antimicrobial susceptibility
testing and detection of ESBL
After superficial cleaning of wounds with physiological
saline, a specimen was collected by rotating a sterile
swab across the surface of the lesion, specifically target-
ing moist and necrotic areas. The specimens were placed
in sterile tubes without transport medium at 4°C imme-
diately after sampling and were processed within 2 h at
the Pasteur Institute medical laboratory in Bangui. Sheep
blood, chocolate and bromocresol purple agar plates
were inoculated, incubated aerobically at 37°C and ex-
amined after 24 h and 48 h. Obligate anaerobes were not
isolated. Bacterial isolates were identified by standard
microbiological methods. Antibacterial drug susceptibil-
ity was determined by the disc diffusion method on
Mueller–Hinton agar (Bio-Rad, Marnes La Coquette,
France), according to the guidelines of the French Society
of Microbiology (http://www.sfm-microbiologie.org).
Production of ESBL in C3G-R Enterobacteriaceae was
detected by the double-disc synergy test [24] and the
MICs of ertapenem by the E-test method (AB Biodisk,Solna, Sweden). The ertapenem cut-off values were used
for categorization. Susceptible strains were defined by
MIC ≤ 0.5 mg/L and resistant strains by MIC >1 mg/L.
All C3G-R Enterobacteriaceae were kept for further
molecular analysis.
DNA extraction and detection of beta-lactamase and
plasmid-mediated quinolone resistance genes
Genomic DNA was extracted with the QIAmp™ kit (Qia-
gen, Courtaboeuf, France). Previously described poly-
merase chain reaction (PCR) methods were used to
screen for plasmid-encoded blaCTX-M and blaSHV beta-
lactamase genes, the aac(6′)-Ib gene and the quinolone
resistance qnrA/B/S and qepA genes [24]. blaCTX-M and
blaSHV were then characterized by direct DNA sequen-
cing of the PCR products. All aac(6′)-Ib positive strains
were further analysed by digestion with BtsCl (New Eng-
land Biolabs, Ipswich, Massachusetts, USA) of the PCR
product to identify aac(6′)-Ib-cr [24].
Repetitive extragenic palindromic PCR, enterobacterial
repetitive intergenic consensus sequence PCR and
multilocus sequence typing
In order to assess the closeness of clonal relations between
isolates at the local level, repetitive extragenic palindromic-
PCR (REP-PCR) and enterobacterial repetitive intergenic
consensus sequence-PCR (ERIC-PCR) were performed
with REP-1R, REP-2 T and ERIC-2, respectively, as
described previously [25]. Strains with an identical ERIC-
PCR and REP-PCR banding pattern were defined as
clonally related.
Multilocus sequence typing of E. coli strains was per-
formed as recommended (http://mlst.ucc.ie/) on one strain
randomly selected for each of the identical REP- and ERIC-
PCR banding patterns. All isolates of ST131 were analysed
by duplex PCR targeting the pabB and trpA genes to
determine whether the isolate belonged to the O25b-
ST131 group [2].
Transferability of extended-spectrum beta-lactamase
Resistance transfer experiments were carried out on
one randomly selected strain that was representative of
the resistance gene content of each REP- and ERIC-
PCR banding pattern. Conjugations were performed on
solid media with E. coli K12 J5 resistant to sodium azide
as the recipient strain [24]. Transconjugants were selected
on Drigalski agar (Bio-Rad) supplemented with sodium
azide (500 mg/L) and ceftazidime (4 mg/L). Transfer
experiments by electroporation were performed for
non-conjugative plasmids. Plasmid DNA from donors
was extracted with a Qiagen plasmid midi kit (Qiagen,
Courtaboeuf, France). Purified plasmids were used
to transform E. coli DH10B (Invitrogen, Cergy-Pontoise,
France) by electroporation according to the manufacturer’s
Rafaï et al. BMC Microbiology  (2015) 15:15 Page 9 of 10instructions (Bio-Rad). Transformants were incubated
at 37°C for 1.5 h and then selected on Drigalski agar
(Bio-Rad) supplemented with 2.5 μg/mL cefotaxime.
Transconjugants and transformants were tested for
ESBL production followed by PCR amplification of the
ESBL and plasmid-mediated quinolone resistance genes,
as well as by plasmid replicon typing.Plasmid replicon type determination
PCR-based replicon-typing analysis was performed as de-
scribed previously [26]. Plasmids belonging to IncF were
typed according to a replicon sequence typing scheme [27].Data analysis
Microsoft Access 2003 was used for data entry, and
Stata version 11 for statistical analysis. The chi-squared
test and Student’s t test were used to compare cate-
gorical and continuous variables in univariate analysis,
respectively. We considered p values < 0.05 to indicate
significant associations.
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